Sai Life Sciences shares rally 9% after Q2 results; net profit rises 17%, revenue up 23%
Sai Life Sciences shares jumped nearly 9% to a fresh 52-week high after strong second-quarter results. Revenue rose 23%, while net profit increased 17%, supported by sustained business momentum and growing engagement with global pharmaceutical companies.
Sai Life Sciences stock rose 9% after the pharmaceutical company released its Q2FY27 financial results, with net profit increasing 17% year-over-year and revenue from operations growing 23%. The company's net profit reached Rs 98 crore, compared to Rs 84 crore in the previous quarter, while revenue from operations rose to Rs 659 crore, up from Rs 537 crore.
EBITDA grew by 20% to Rs 187 crore, but the profit after tax margin fell slightly to 15%. For the first half of FY27, revenue increased 17% to Rs 1,213 crore, EBITDA grew 19% to Rs 335 crore, and PAT rose 19% to Rs 172 crore. The company spent Rs 621 crore on capital expenditure during the first half of FY27. Sai Life Sciences CEO Krishna Kanumuri attributed the strong results to sustained business momentum and progress in strategic priorities, including increased traction with global pharmaceutical firms and expansion of customer relationships.
Written by urgent.news from The Economic Times - Top News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
